Diamond Therapeutics Appoints Renowned Psychiatrist and Author Dr. Torsten Passie to Scientific Advisory Board

/PRNewswire/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic therapies for use in the treatment of mental...

Related Keywords

Germany ,Arizona ,United States ,Hannover ,Niedersachsen ,New Zealand ,Toronto ,Ontario ,Canada ,Otago ,Frankfurt ,Brandenburg ,Hazel Buckland ,Torsten Passie ,Thomas Kosten ,Joseph Moskal ,Williamj Tyler ,Ethics In Medicine At Goethe University Frankfurt ,University Of Toronto ,Dunedin School Of Medicine ,University Of Otago ,Diamond Therapeutics Inc ,Molecular Therapeutics At Northwestern University ,Senckenberg Institute Of History ,Laboratory For Neurocognition ,Falk Center ,Senckenberg Institute For History ,Hannover Medical School ,Danl Duncan Institute For Clinical ,Hannover Medical School In ,Harvard Medical School ,Goethe University Frankfurt ,Translational Research At Baylor College Of Medicine ,Health Systems Engineering At Arizona State University ,Senckenberg Institute ,Goethe University ,Microdosing Psychedelics ,Edward Sellers ,Paul Glue ,Hazel Buckland Chair ,Dunedin School ,Translational Research ,Baylor College ,Molecular Therapeutics ,Health Systems Engineering ,Arizona State ,